Test Price
950 AED✅ Home Collection Available
Enterovirus (RNA Detection) Qualitative Test in UAE | 950 AED | 2026 DHA Guidelines
تحليل الكشف النوعي عن الحمض النووي الريبوزي للفيروس المعوي في الإمارات | 950 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
الملخص التنفيذي: يقوم اختبار الكشف النوعي للحمض النووي الريبوزي للفيروس المعوي (RNA) بتحديد وجود الفيروس في العينات السريرية بسرعة ودقة عالية باستخدام تقنية تفاعل البوليميراز المتسلسل (PCR)، مما يضمن تشخيصًا موثوقًا ومعتمدًا من هيئة الصحة بدبي وفقًا لأحدث الإرشادات لعام 2026.
The Enterovirus RNA Qualitative Detection Test identifies viral RNA in whole blood, serum, stool, CSF, and plasma using Real‑Time PCR, delivering 99.9% diagnostic sensitivity. Results are available within 24 hours by phone and 36 hours by email, backed by ISO 9001:2015‑certified processing and direct insurance verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM‑11 PM).
- Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
This qualitative PCR test detects enteroviral RNA in stool, CSF, or blood, establishing a definitive aetiology for febrile syndromes, aseptic meningitis, and hand‑foot‑and‑mouth disease. بالعربية: يكشف الاختبار عن وجود الحمض النووي الريبوزي للفيروس المعوي في عينات البراز أو السائل النخاعي أو الدم، مؤكداً التشخيص للمتلازمات الحموية والتهاب السحايا العقيم ومرض اليد والقدم والفم.
| Feature | Our Test (Real‑Time PCR) | Closest Alternative (Viral Culture / Serology) |
|---|---|---|
| Precision | 99.9% sensitivity; directly detects viral RNA | Culture: slow growth, poor sensitivity; Serology: reflects past exposure |
| Turnaround Time | 24 h phone / 36 h email | Culture: 3–10 days; Serology: 1–3 days |
| Clinical Impact | Rapid diagnosis guides isolation, stops antibiotics | Delayed results may lead to unnecessary treatment |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011) notes: “Enterovirus infections can present with a wide spectrum of symptoms; a positive result must be interpreted alongside clinical presentation. Timely detection via PCR can guide appropriate management and avoid unnecessary antibiotics. Always consult your physician before making any treatment decisions.”
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Hemodynamic instability requiring ICU – do not delay emergency care for specimen collection.
- Asymptomatic screening is not recommended; test only when enterovirus‑compatible symptoms are present.
- If severe symptoms appear (high fever with neck stiffness, photophobia, persistent vomiting, altered consciousness, or non‑blanching rash in children), proceed to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
What is the enterovirus RNA detection test?
Enterovirus RNA detection qualitative uses real-time PCR to identify viral genetic material in clinical specimens with high sensitivity. It can pinpoint the virus in stool, cerebrospinal fluid, blood, or other body fluids, allowing clinicians to rapidly confirm the cause of diverse illnesses ranging from mild febrile rashes to severe aseptic meningitis and myocarditis.
How quickly will I receive my results?
Results are typically available within 24 hours by phone and 36 hours via email, ensuring rapid clinical decision‑making. Our ISO‑accredited laboratory processes samples on the same business day, and the 24‑hour phone notification enables immediate physician consultation if a positive result is detected.
What sample types are accepted and how is collection arranged?
Stool, whole blood, serum, plasma, and cerebrospinal fluid (CSF) are all accepted; stool is often preferred for gastrointestinal presentations. Our VIP mobile phlebotomy team collects samples at your home or office between 8 AM and 11 PM using strict cold‑chain protocols, and stool containers are provided with clear instructions to maintain viability.
أسئلة متكررة: يقبل الاختبار عينات البراز والدم الكامل والمصل والبلازما والسائل النخاعي، ويتم جمع العينات منزلياً بواسطة فريق متخصص مع الالتزام بسلسلة التبريد.
Federal Decree-Law No. 41 of 2024 (Art. 87) applies. CDS Law 2026: guardian consent mandatory for minors. UAE PDPL ensures data privacy. Facility License: 9834453. ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians